Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age

Pediatric Blood and Cancer

Volumn 60, Issue 4, 2013, Pages 700-704

  Levy, Jean M Mulcahy ^a   Tello, Tiffany ^b   Giller, Roger ^a   Wilkening, Greta ^a   Quinones, Ralph ^a   Keating, Amy K ^a   Liu, Arthur K ^a,b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

ALL; BMT; Late effects of cancer treatment; Radiation therapy; Total body irradiation

Indexed keywords

CREATININE;

ARTICLE; CATARACT; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; COGNITION; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZED CHILD; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INFANT; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; OSTEOCHONDROMA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION RESPONSE; RETROSPECTIVE STUDY; SHORT STATURE; SKELETON MALFORMATION; SURVIVOR; UREA NITROGEN BLOOD LEVEL; WHOLE BODY RADIATION;

CHILD, PRESCHOOL; COGNITION DISORDERS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; SURVIVORS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 84873733951     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24252     Document Type: Article

References (24)

1. Bunin N, Aplenc R, Kamani N, et al. Randomized trial of busulfan vs. total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study. Bone Marrow Transplant 2003; 32: 543-548.
2. Dusenbery KE, Daniels KA, McClure JS, et al. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. Int J Radiat Oncol Biol Phys 1995; 31: 119-128.
3. Davies SM, Ramsay NK, Klein JP, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000; 18: 340-347.
4. Baker KS, Bresters D, Sande JE. The burden of cure: Long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am 2010; 57: 323-342.
5. Leung W, Hudson M, Zhu Y, et al. Late effects in survivors of infant leukemia. Leukemia 2000; 14: 1185-1190.
6. Perkins JL, Kunin-Batson AS, Youngren NM, et al. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007; 49: 958-963.
7. Faraci M, Barra S, Cohen A, et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63: 1568-1575.
8. Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 2008; 41: 223-227.
9. Chemaitilly W, Sklar CA. Endocrine complications of hematopoietic stem cell transplantation. Endocrinol Metab Clin North Am 2007; 36: 983-998; ix.
10. Marcovici PA, Berdon WE, Liebling MS. Osteochondromas and growth retardation secondary to externally or internally administered radiation in childhood. Pediatr Radiol 2007; 37: 301-304.
11. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 356: 993-997.
12. Chow EJ, Simmons JH, Roth CL, et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant 2010; 16: 1674-1681.
13. Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83: 382-395.
14. Lanes R. Metabolic abnormalities in growth hormone deficiency. Pediatr Endocrinol Rev 2004; 2: 209-215.
15. Maison P, Griffin S, Nicoue-Beglah M, et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: A metaanalysis of blinded, randomized, placebo-controlled trials. J Clin Endocrinol Metab 2004; 89: 2192-2199.
16. Murray RD, Wieringa G, Lawrance JA, et al. Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness. Clin Endocrinol (Oxf) 73: 508-515.
17. van Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: Influence of treatment parameters. Int J Radiat Oncol Biol Phys 2000; 48: 807-815.
18. van Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract after total body irradiation and bone marrow transplantation: Degree of visual impairment. Int J Radiat Oncol Biol Phys 2002; 52: 1375-1380.
19. Gurney JG, Ness KK, Rosenthal J, et al. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: Results from the bone marrow transplant survivor study. Cancer 2006; 106: 1402-1408.
20. van Kempen-Harteveld ML, van Weel-Sipman MH, Emmens C, et al. Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: Risks and benefits. Bone Marrow Transplant 2003; 31: 1151-1156.
21. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 2005; 23: 7152-7160.
22. Phipps S, Rai SN, Leung WH, et al. Cognitive and academic consequences of stem-cell transplantation in children. J Clin Oncol 2008; 26: 2027-2033.
23. Smedler AC, Bolme P. Neuropsychological deficits in very young bone marrow transplant recipients. Acta Paediatr 1995; 84: 429-433.
24. Smedler AC, Nilsson C, Bolme P. Total body irradiation: A neuropsychological risk factor in pediatric bone marrow transplant recipients. Acta Paediatr 1995; 84: 325-330.